NYKODE THERAPEUTICS ASA

Home - Nykode

The Nykode Therapeutics platform is built around the Vaccibody molecule: A vaccine platform for the future of medicine.

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: MT
Michael Thyrring Engsig1972
Chairman of the board: AG
Alf Gunnar Martin Nicklasson1955
Years since formation: 17 years; since Jan 13, 2007
Type: Public limited company
VAT registered: Yes
Number of employees: 140

Ownership

Number of shares and share classes: 326,546,444; 1 share class
Total number of shareholders: 7456; 1,071 companies, 6,385 persons

Financials

Total operating income 2023: 13,362,000; NOK
Annual total result 2023: -33,392,000; NOK
Total equity 2023: 174,832,000; NOK

Last update: Sep 12, 2024

Management

Management / administration

Name	Role	Shares
MT Michael Thyrring Engsig 1972	Managing Director/CEO	-

Board

Name	Role	Shares
AG Alf Gunnar Martin Nicklasson 1955	Chairman	-
BR Bernd Robert Seizinger 1956	Board Member	-
CÅ Christian Åbyholm 1972	Board Member	-
BV Birgitte Volck 1962	Board Member	-
AC Anne Clem Whitaker 1967	Board Member	-
ES Elaine Sullivan 1961	Board Member	-
TL Trygve Lauvdal 1969	Observer	-
HA Harald Arnet 1961	Board Member	-
EJ Einar Jørgen Greve 1960	Board Member	-

Others

Name	Role	Shares
D DELOITTE AS	Auditor	-
A AMESTO ACCOUNTHOUSE AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
AC Alexandra Caroline Haudemann-Andersen 1989	-	7.41 % indirectly
JH Jan Haudemann-Andersen 1958	-	4.95 % directly 0.07 % indirectly 4.88 %
RV Runar Vatne 1974	-	2.54 % directly 0.23 % indirectly 2.31 %
OM Ole Morten Halvorsen 1960	-	2 % indirectly
ST Simen Thorsen 1977	-	1.82 % directly 0.2 % indirectly 1.62 %
SV Stein Vidar Haudemann-Andersen 1955	-	1.37 % indirectly
HA Hilde Andenæs 1971	-	1.35 % indirectly
UW Una Andenæs Westvold 2000	-	1.33 % indirectly
EW Eva Andenæs Westvold 2003	-	1.33 % indirectly
EA Edvin Austbø 1964	-	1.29 % directly 0.05 % indirectly 1.25 %

Last update: Aug 21, 2024

Ownership

Company shareholders

Name	Share class	Number of shares	Share
R RASMUSSENGRUPPEN AS	NO0010714785	30,180,750	9.24 %
D DATUM OPPORTUNITY AS	NO0010714785	26,000,000	7.96 %
R RADFORSK INVESTERINGSSTIFTELSE	NO0010714785	24,057,000	7.37 %
V VICTORIA INDIA FUND AS	NO0010714785	17,705,175	5.42 %
SS Street Bank And Trust Comp State	NO0010714785	12,735,824	3.9 %
D DATUM AS	NO0010714785	12,560,250	3.85 %
J JOH JOHANNSON EIENDOM AS	NO0010714785	10,561,631	3.23 %
N NORDA ASA	NO0010714785	7,996,755	2.45 %
V VATNE EQUITY AS	NO0010714785	7,485,857	2.29 %
O OM HOLDING AS	NO0010714785	6,519,525	2 %
H HORTULAN AS	NO0010714785	5,184,808	1.59 %
P PORTIA AS	NO0010714785	4,500,000	1.38 %
K KRAG INVEST AS	NO0010714785	4,470,100	1.37 %
A ALDEN AS	NO0010714785	4,202,500	1.29 %
MJ Morgan Se Jp	NO0010714785	3,510,780	1.08 %
S SKIPS AS TUDOR	NO0010714785	3,365,000	1.03 %
V VERDIPAPIRFONDET DANSKE INVEST NORGE VEKST	NO0010714785	3,137,203	0.96 %
S SKØIEN AS	NO0010714785	3,000,000	0.92 %
B BORGANO AS	NO0010714785	3,000,000	0.92 %
V VERDIPAPIRFONDET DANSKE INVEST NORSKE AKSJER INSTITUSJON II	NO0010714785	2,833,200	0.87 %
L LANI INVEST AS	NO0010714785	2,399,916	0.73 %
D DATUM FINANS AS	NO0010714785	2,395,500	0.73 %
T The Northern Trust Comp, London Br	NO0010714785	2,383,699	0.73 %
C CAABY AS	NO0010714785	2,055,295	0.63 %
S SP CAPITAL 22 AS	NO0010714785	2,000,000	0.61 %
ES Enskilda Banken Ab Skandinaviska	NO0010714785	1,929,662	0.59 %
S SARSIA SEED AS	NO0010714785	1,925,000	0.59 %
F FOUGNER INVEST AS	NO0010714785	1,904,477	0.58 %
V VIGINTI AS	NO0010714785	1,882,900	0.58 %
C CIPRIANO AS	NO0010714785	1,775,000	0.54 %
CJ Chase Bank Na London Jpmorgan	NO0010714785	1,723,288	0.53 %
BB Bjarne Bogen 1951	NO0010714785	1,609,741	0.49 %
V VERDIPAPIRFONDET FIRST GENERATOR	NO0010714785	1,578,989	0.48 %
M MELESIO INVEST AS	NO0010714785	1,366,305	0.42 %
A ALTITUDE CAPITAL AS	NO0010714785	1,350,000	0.41 %
C CRESSIDA AS	NO0010714785	1,350,000	0.41 %
TY Timothy Churk Yue Yip 1971	NO0010714785	1,210,109	0.37 %
L LIONESS AS	NO0010714785	1,202,042	0.37 %
TE Tom Edward Pike 1960	NO0010714785	1,120,831	0.34 %
JF Jostein Fredriksen 1976	NO0010714785	1,100,000	0.34 %
H HIFO INVEST AS	NO0010714785	1,100,000	0.34 %
H HAADEM INVEST AS	NO0010714785	1,070,000	0.33 %
S STAFF-GRUPPEN AS	NO0010714785	1,000,000	0.31 %
L LITHINON AS	NO0010714785	1,000,000	0.31 %
T TIGERSTADEN AS	NO0010714785	1,000,000	0.31 %
D DUKAT AS	NO0010714785	953,013	0.29 %
P P53 INVEST AS	NO0010714785	950,762	0.29 %
S SONGA CAPITAL AS	NO0010714785	948,979	0.29 %
S Sirius AS	NO0010714785	925,000	0.28 %
V VERDIPAPIRFONDET EQUINOR AKSJER NORGE	NO0010714785	922,600	0.28 %
F FINYIELD AS	NO0010714785	915,000	0.28 %
V VERDIPAPIRFONDET KLP AKSJENORGE INDEKS	NO0010714785	913,119	0.28 %
A ACADIA HOLDING AS	NO0010714785	885,000	0.27 %
S SCAN CHEMICALS AS	NO0010714785	875,000	0.27 %
T TRIONOR AS	NO0010714785	840,000	0.26 %
A AREPO AS	NO0010714785	830,000	0.25 %
R RAMS INVEST AS	NO0010714785	800,000	0.24 %
S STRIGEN AS	NO0010714785	770,000	0.24 %
F FACULTAS AS	NO0010714785	762,500	0.23 %
V VERDIPAPIRFONDET EIKA NORGE	NO0010714785	752,129	0.23 %
N NASA AS	NO0010714785	750,000	0.23 %
SS Street Bank And Trust Comp State	NO0010714785	746,449	0.23 %
RV Runar Vatne 1974	NO0010714785	745,020	0.23 %
T T.D. VEEN AS	NO0010714785	728,582	0.22 %
C CATILINA INVEST AS	NO0010714785	719,000	0.22 %
V VERDIPAPIRFONDET STOREBRAND INDEKS - NORGE	NO0010714785	706,999	0.22 %
K KOMMUNAL LANDSPENSJONSKASSE GJENSIDIG FORSIKRINGSSELSKAP	NO0010714785	704,470	0.22 %
C Clearstream Banking S.a.	NO0010714785	703,269	0.22 %
T The Bank Of New York Mellon Sa/Nv	NO0010714785	684,091	0.21 %
ST Simen Thorsen 1977	NO0010714785	661,660	0.2 %
MJ Morgan Se Jp	NO0010714785	657,682	0.2 %
S SPÅLEN GENERASJON AS	NO0010714785	645,000	0.2 %
V VERDIPAPIRFONDET EIKA SPAR	NO0010714785	638,353	0.2 %
T The Bank Of New York Mellon Sa/Nv	NO0010714785	623,787	0.19 %
MJ Marius Jørgensen 1968	NO0010714785	610,000	0.19 %
ES Enskilda Banken Ab Skandinaviska	NO0010714785	600,000	0.18 %
MJ Morgan Se Jp	NO0010714785	574,457	0.18 %
L LIE HOLDING AS	NO0010714785	562,909	0.17 %
IA Ingrid Alfheim 1946	NO0010714785	554,034	0.17 %
G GÅSØ NÆRINGSUTVIKLING AS	NO0010714785	550,000	0.17 %
K KRANSTAD INVEST AS	NO0010714785	550,000	0.17 %
CJ Chase Bank Na London Jpmorgan	NO0010714785	504,757	0.15 %
K KLØVNINGEN AS	NO0010714785	500,000	0.15 %
V VERDIPAPIRFONDET KLP AKSJENORGE AKTIV	NO0010714785	500,000	0.15 %
Ø ØRN AS	NO0010714785	500,000	0.15 %
R RTTM HOLDING AS	NO0010714785	500,000	0.15 %
E ELAR HOLDING AS	NO0010714785	500,000	0.15 %
JH Johan Henrik Krefting 1970	NO0010714785	500,000	0.15 %
B BECK ASSET MANAGEMENT AS	NO0010714785	500,000	0.15 %
N NORDNET LIVSFORSIKRING AS	NO0010714785	474,296	0.15 %
S STOKO AS	NO0010714785	470,000	0.14 %
L LYNX UNLIMITED AS	NO0010714785	469,020	0.14 %
V VERDIPAPIRFONDET NORDEA NORWEGIAN PASSIVE ESG FUND	NO0010714785	455,206	0.14 %
G GUNNAR LANDGRAFF AS	NO0010714785	450,000	0.14 %
V VERDIPAPIRFONDET DANSKE INVEST NORSKE AKSJER INSTITUSJON I	NO0010714785	445,100	0.14 %
V VERDIPAPIRFONDET ALFRED BERG INDEKS	NO0010714785	427,000	0.13 %
JA Jarle Anton Johnsen 1953	NO0010714785	421,695	0.13 %
V VJ INVEST AS	NO0010714785	402,436	0.12 %
M MIDDELBORG INVEST AS	NO0010714785	399,737	0.12 %
S SANDNES INVESTERING AS	NO0010714785	390,000	0.12 %

Last update: May 24, 2024

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	13,362,000	9,029,000	35,766,000
Annual Total Result	-33,392,000	-41,680,000	-8,597,000
Total assets	210,353,000	223,706,000	265,755,000
Total liabilities	35,521,000	64,880,000	70,888,000
Total equity	174,832,000	158,826,000	194,866,000

P&L

Year	2023	2022	2021
Total operating income	13,362,000	9,029,000	35,766,000
Total operating costs	69,842,000	61,177,000	45,682,000
Operating result	-56,480,000	-52,148,000	-9,916,000
Financial income/costs	14,051,000	2,148,000	-412,000
Profit before tax	-42,429,000	-50,000,000	-10,328,000
Total tax & extraordinary income/cost	-9,037,000	-8,320,000	-1,731,000
Annual Total Result	-33,392,000	-41,680,000	-8,597,000

Balance overview

Year	2023	2022	2021
Total fixed assets	45,910,000	12,636,000	10,527,000
Total current assets	164,443,000	211,070,000	255,228,000
Total assets	210,353,000	223,706,000	265,755,000
Short term debt	19,855,000	39,406,000	30,754,000
Long term debt	15,666,000	25,474,000	40,134,000
Total liabilities	35,521,000	64,880,000	70,888,000
Contributed capital	141,633,000	83,656,000	89,708,000
Retained earnings	33,199,000	75,170,000	105,158,000
Total equity	174,832,000	158,826,000	194,866,000
Total equity and liabilities	210,353,000	223,706,000	265,754,000

NYKODE THERAPEUTICS ASA990 646 066